Abbvie (($ABBV)) announced an update on their ongoing clinical study. AbbVie recently updated its clinical study titled A ...

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the body’s natural immune system as well as some therapies. A new study uses novel ...

Gilead has chosen a partner for lenacapavir in the race to develop new low-frequency treatments for HIV. | Gilead has chosen ...

Merck's two-drug HIV regimen doravirine/islatravir maintained viral suppression and matched Gilead's Biktarvy in Phase 3 ...

Leaders in HIV research highlighted the critical role of that research has played in advancing HIV science over the past 40 years. In a commentary in Nature Medicine, they explained how U.S.-funded ...

The rate of HIV infection continues to climb globally. Around 40 million people live with HIV-1, the most common HIV strain.

More than 40 years have passed since the CDC reported the first cases of HIV in the United States. In that time, we’ve ...

The NIH funding will help address a "traditional barrier" to health care, says Elizabeth Evans, professor of community health ...

UN World Children's Day on Nov 20 is an annual reminder that every child deserves the chance not just to survive, but to ...

"You know, it's not the best news. But there was other news that could have been a lot worse, you know?" Charlie Sheen said.

More than 230 people became infected with HIV in Indiana, worsened by delayed action from former Gov. Mike Pence. Experts and ...

People living with HIV who smoke are currently more likely to die from lung cancer than from HIV-related causes. Two cancer ...